| Q40855733 | A new approach to AIDS research and prevention: the use of gene-mutated HIV-1/SIV chimeric viruses for anti-HIV-1 live-attenuated vaccines |
| Q36397434 | A species-specific amino acid difference in the macaque CD4 receptor restricts replication by global circulating HIV-1 variants representing viruses from recent infection |
| Q35884012 | Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of simian/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS |
| Q34070178 | CD4+-T-cell and CD20+-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques. |
| Q58596199 | CXCR4- and CCR5-Tropic HIV-1 Clones Are Both Tractable to Grow in Rhesus Macaques |
| Q35885915 | Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys |
| Q35860556 | Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques |
| Q73139046 | Comparative histopathological studies in the early stages of acute pathogenic and nonpathogenic SHIV-infected lymphoid organs |
| Q40536044 | Developing animal models for AIDS research--progress and problems |
| Q41144765 | Development of SHIVs with circulating, transmitted HIV-1 variants |
| Q39231199 | Generation of a replication-competent chimeric simian-human immunodeficiency virus carrying env from subtype C clinical isolate through intracellular homologous recombination |
| Q41253393 | Genetic complementation between replication-defective mutants of HIV-1 and SIVagm |
| Q36099212 | Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques |
| Q45753693 | In vitro infection of primate PBMC with simian/human immunodeficiency virus, SHIV(SF33A): correlation to in vivo outcome |
| Q45721995 | In vivo inactivation of Nef ITAM motif of chimeric simian/human immunodeficiency virus SHIVsbg-YE correlates with absence of increased virulence in Chinese rhesus macaques |
| Q37316026 | Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development. |
| Q28775731 | Persistent infection of macaques with simian-human immunodeficiency viruses |
| Q34060230 | Persistent infection of rhesus macaques with T-cell-line-tropic and macrophage-tropic clones of simian/human immunodeficiency viruses (SHIV) |
| Q37034639 | Perspectives for a protective HIV-1 vaccine |
| Q33878670 | Primate models of AIDS. |
| Q33647300 | Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. |
| Q35084605 | Rhesus M1.3S Cells Suitable for Biological Evaluation of Macaque-Tropic HIV/SIV Clones |
| Q39594428 | Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. |
| Q35861970 | Simian immunodeficiency virus DNA vaccine trial in macaques. |
| Q41413292 | Simian immunodeficiency virus as a model of HIV pathogenesis |
| Q33810425 | Simian-human immunodeficiency virus containing a human immunodeficiency virus type 1 subtype-E envelope gene: persistent infection, CD4(+) T-cell depletion, and mucosal membrane transmission in macaques |
| Q36511937 | Study human pancreatic cancer in mice: how close are they? |
| Q39582443 | Substitutions in a major histocompatibility complex class II-restricted human immunodeficiency virus type 1 gp120 epitope can affect CD4+ T-helper-cell function. |
| Q37365618 | The role of neutralizing antibodies in prevention of HIV-1 infection: what can we learn from the mother-to-child transmission context? |
| Q38764543 | Use of broadly neutralizing antibodies for HIV-1 prevention |
| Q74613240 | Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine |
| Q35860324 | Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques |
| Q36602273 | Virus-like particles: designing an effective AIDS vaccine |